Header cover image
  • Investing Ideas
  • /
  • Swiss Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Swiss Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

1

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

1 companies

Novartis

Market Cap: CHF 183.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 94.72

7D

2.8%

1Y

-3.8%